Overview
Chlamydia trachomatis is an obligate intracellular Gram-negative bacterium and the causative agent of the most common bacterial sexually transmitted infection (STI) worldwide, with an estimated 127 million new cases annually according to the World Health Organization. Unlike most bacteria, C. trachomatis cannot replicate outside of host cells and relies entirely on the host for ATP and other essential metabolites. The organism has a unique biphasic developmental cycle alternating between the infectious elementary body (EB) and the replicating reticulate body (RB), which allows it to persist within host epithelial cells and evade immune detection.
Classification
C. trachomatis belongs to the phylum Chlamydiae, class Chlamydiia, order Chlamydiales, and family Chlamydiaceae. The species is divided into 18 serovars with dramatically different tissue tropisms despite sharing approximately 95% genomic identity. Serovars A, B, Ba, and C cause ocular trachoma, the leading infectious cause of preventable blindness worldwide. Serovars D through K cause urogenital infections including cervicitis, urethritis, and pelvic inflammatory disease (PID). Serovars L1, L2, and L3 cause lymphogranuloma venereum (LGV), an invasive infection that spreads to lymph nodes and demonstrates unique macrophage tropism.
Key Characteristics
The obligate intracellular lifestyle of C. trachomatis is its most defining characteristic. Elementary bodies attach to and enter host epithelial cells, forming a membrane-bound inclusion within which they differentiate into reticulate bodies that divide by binary fission. After 48-72 hours of replication, RBs convert back to EBs and are released to infect new cells. This intracellular niche protects the organism from many host immune defenses and antibiotics that do not penetrate cells effectively. Cell-type-specific tropism is driven by surface protein polymorphisms: urogenital epithelial cells support robust replication of serovars D and L2, while macrophages restrict serovar D but permit L2 proliferation. The organism elicits serovar-specific cytokine responses including GM-CSF, RANTES, IL-1, and IL-8.
Health Significance
C. trachomatis infection is a major global health concern. In the urogenital tract, the majority of infections are asymptomatic, particularly in women, which facilitates ongoing transmission and delayed diagnosis. Untreated infections can ascend to cause pelvic inflammatory disease, potentially leading to tubal scarring, ectopic pregnancy, and infertility. From a microbiome perspective, the vaginal microbiome composition appears to play a significant role in susceptibility to chlamydial infection. A Lactobacillus-dominant vaginal microbiome is generally associated with lower STI susceptibility, while a diverse, Gardnerella-enriched community may increase vulnerability. Screening with nucleic acid amplification tests (NAAT) and treatment with azithromycin or doxycycline are the standard approach to controlling chlamydial infections. While C. trachomatis is not detected on standard gut microbiome panels, understanding the interplay between the urogenital microbiome and STI susceptibility remains an important area of research.